Anthem Blue Cross Connecticut CG-MED-51 Three-Dimensional (3-D) Rendering of Imaging Studies Form

Effective Date

09/27/2023

Last Reviewed

08/10/2023

Original Document

  Reference



This document addresses three-dimensional (3-D) rendering of imaging studies. 3-D rendering uses multiple thin sections of images and reconstructs them into 3-D images which can display anomalies or structures and enhance visualization of pathology. This technology may also be referred to as 3-D reconstruction or 3-D reformation.

Note: This document does not address CT Colonography (Virtual Colonoscopy), 3-D fetal ultrasound or 3-D mammography (digital breast tomosynthesis). Please see the following related document for additional information:

  • RAD.00038 Use of 3-D, 4-D or 5-D Ultrasound in Maternity Care

Clinical Indications

Medically Necessary:

The use of 3-D image rendering is considered medically necessary for clinical evaluation or preoperative planning when the information provided cannot be obtained by traditional two-dimensional (2-D) imaging and is critical to the clinical management of the individual. Common indications for 3-D image rendering include, but are not limited to:

  1. Aneurysms, suspected or known (computed tomography angiography [CTA]); or
  2. Complex fractures (computed tomography [CT]); or
  3. To localize and characterize blood supply to congenital abnormalities for the purpose of diagnosis and treatment planning (CTA); or
  4. Eagle syndrome (CT); or
  5. Gynecologic ultrasound (US) indications (3D should not be performed routinely with all pelvic sonograms):
    1. Abscess drainage in the pelvis and abdomen; or
    2. Congenital anomalies of the uterus; or
    3. Evaluation of the endometrium and uterine cavity, if symptomatic (for example, abnormal bleeding); or
    4. Infertility; or
    5. Planned myomectomy-mapping of uterine fibroids; or
    6. Cornual ectopic pregnancies; or
    7. Diethylstilbestrol (DES) exposure; or
    8. Intrauterine device location, if symptomatic (for example, abnormal bleeding or pain); or
    9. Imaging of adnexal lesions; or
  6. Mass, tumor, or other abnormal structure previously identified on imaging (CT, MRI); or
  7. Prior to computer-assisted endoscopic sinus surgery or stereotactic computer assisted volumetric intracranial surgery (CT); or
  8. Pectus deformity (CT); or
  9. Scoliosis, adolescent idiopathic (US); or
  10. Thromboembolic disease (CTA); or
  11. Prior to organ transplantation for anatomic mapping (CTA); or
  12. Prior to kidney or renal surgery (CT); or
  13. Trauma, to assess for presence and location of vascular, solid organ, and visceral organ injury and hemorrhage, and determine the appropriate management option (CTA); or
  14. Trauma, complex facial (CT); or
  15. When used with magnetic resonance cholangiopancreatography (MRCP); or
  16. When used with echocardiography if the information produced from the 3D echocardiogram cannot be provided by a traditional 2D echocardiogram, or other testing for any of the following:
    1. Evaluation of congenital heart disease; or
    2. Preoperative planning of a cardiac procedure; or
    3. Planned use of cardiotoxic chemotherapy.

Not Medically Necessary:

The use of 3-D image rendering is considered not medically necessary when the criteria above are not met, and for the following:

  • When information provided can be obtained by traditional 2-D imaging (such as US, CT, MRI);
  • For use with an imaging study that is considered not medically necessary or investigational and not medically necessary;
  • For routine use without specifically being ordered by the requesting physician (such as the routine use with ultrasound).